Skip to content
healthcare.dev

Xeomin

NDC 0259-1610, incobotulinumtoxinA, injection, powder, lyophilized, for solution, from Merz Pharmaceuticals, LLC.

Product NDC
0259-1610
Status
Listed
Labeler
Merz Pharmaceuticals, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125360
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0259-1610 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOTULINUM TOXIN TYPE A100 [USP'U]/1

Pharmacologic classes

Acetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Neuromuscular Blockade [PE]; Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
0259-1610-01002591610011 VIAL, SINGLE-USE in 1 CARTON (0259-1610-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ccdc3aae-6e2d-4cd0-a51c-8375bfee9458
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0259-1610

Use it

Look up 0259-1610 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0259-1610 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0259-1610. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.